News & Insights

Featured story

09 June 2020

36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live

Professor Thomas Zeller (University Heart Centre Freiburg, Bad Krozingen, Germany) today presented the 36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live.

More stories

Press releases

06 April 2021 | 17:14 PM CEST
Veryan Medical announces multimillion-euro investment in Galway operation

Galway, 06 April 2021 Veryan has announced a multimillion-euro investment at its Galway facility that will contribute to the further expansion and diversification of Veryan’s product portfolio beyond the BioMimics 3D Swirling Flow stent, marketed in Europe and USA to improve blood flow through arteries in the leg.

16 December 2020 | 16:28 PM CET
First patient enrolment in MIMICS 3D USA

Veryan Medical (Horsham, UK) is delighted to announce that the first patient was enrolled today in the MIMICS-3D USA study by John H. Rundback MD at NJ Endovascular & Amputation Prevention, NJ.

02 September 2020 | 19:02 PM CEST
First BioMimics 3D US Implant

Veryan Medical (Horsham, UK) has announced that Dr. Bret Wiechmann and his team at Vascular and Interventional Physicians in Gainesville, FL implanted the first commercial BioMimics 3D Vascular stent in the US, on the same day that the device was officially launched in the US. The BioMimics 3D self-expanding, nitinol stent features a highly differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up, MIMICS-2.


View upcoming events in the U.S. that Veryan will be participating in.

More from Veryan